ENDOSALPINGIOSIS

This adverse event was reported 11 times

ENDOSALPINGIOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIFEPRISTONE 2 0.0004
1 ESTROGEN 1 0.0003
2 MARC GLASSMAN 1 0.0003
3 ELAGOLIX 1 0.0003
4 DOCUSATE SODIUM AND SENNOSIDES 1 0.0002
5 DOCUSATE CALCIUM 1 0.0002
6 DOCUSATE SODIUM SENNOSIDES 1 0.0002
7 NORETHINDRONE 1 0.0002
8 HUMAN INSULIN 1 0.0001
9 LIOTHYRONINE SODIUM 1 0.0001
See all drugs enriched for association with ENDOSALPINGIOSIS

ENDOSALPINGIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 2 0.0004
1 Vitamin D3 Analog [EPC] 1 0.0000
2 Insulin [EPC] 1 0.0000
3 Copper-containing Intrauterine Device [EPC] 1 0.0000
4 Folate Analog [EPC] 1 0.0000
5 Vitamin A [EPC] 1 0.0000
6 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
7 Nicotinic Acid [EPC] 1 0.0000
8 Antidote [EPC] 1 0.0000
9 Cardiac Glycoside [EPC] 1 0.0000
See all drug classes enriched for association with ENDOSALPINGIOSIS